Nephros (NEPH) Total Non-Current Liabilities (2010 - 2020)
Nephros' (NEPH) quarterly Total Non-Current Liabilities came in at -$5.3 million in Q4 2020, down 245.93% year-on-year from $3.6 million in Q1 2020, and down 239.94% quarter-over-quarter from $3.8 million in Q3 2020.
Nephros (NEPH) Total Non-Current Liabilities (2010 - 2020) Analysis & Trends
Nephros' Total Non-Current Liabilities history runs 9 years deep, the most recent figure standing at -$5.3 million for Q4 2020.
- On a quarterly basis, Total Non-Current Liabilities fell 245.93% year-over-year to -$5.3 million in Q4 2020; TTM through Dec 2020 was -$5.3 million, a 245.93% decrease from a year earlier, with the FY2020 full-year figure at -$5.3 million, down 245.93% from the prior year.
- Total Non-Current Liabilities slipped to -$5.3 million in Q4 2020 per NEPH's latest filing, from $3.8 million in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $5.0 million in Q2 2019 and bottomed at -$5.3 million in Q4 2020.
- The 3-year median for Total Non-Current Liabilities is $4.2 million (2020), against an average of $3.2 million.
- Across the five-year window, Total Non-Current Liabilities climbed 4.09% in 2019 and sank 245.93% in 2020, its largest moves.
- Year by year, Total Non-Current Liabilities stood at $3.5 million in 2018, then gained by 4.09% to $3.6 million in 2019, then sank by 245.93% to -$5.3 million in 2020.
- Per Business Quant, the three latest NEPH Total Non-Current Liabilities figures stand at -$5.3 million (Q4 2020), $3.8 million (Q3 2020), and $4.2 million (Q2 2020).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 6.48 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 1.92 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 48.37 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 17.13 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 941.16 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 996.30 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 4.24 Bn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 8.65 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 2.06 Bn |
| 10 | Nephros | 40.88 Mn | 36.86 Mn | 2.99 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | -5.31 Mn |
| Sep 30, 2020 | 3.80 Mn |
| Jun 30, 2020 | 4.19 Mn |
| Mar 31, 2020 | 4.46 Mn |
| Dec 31, 2019 | 3.64 Mn |
| Sep 30, 2019 | 4.75 Mn |
| Jun 30, 2019 | 5.05 Mn |
| Mar 31, 2019 | 4.30 Mn |
| Dec 31, 2018 | 3.50 Mn |
| Sep 30, 2015 | -3.77 Mn |
| Jun 30, 2015 | 1.75 Mn |
| Mar 31, 2015 | 1.66 Mn |
| Dec 31, 2014 | 1.66 Mn |
| Sep 30, 2014 | -3.63 Mn |
| Jun 30, 2014 | -8.41 Mn |
| Mar 31, 2014 | -3.57 Mn |
| Dec 31, 2013 | 3.59 Mn |
| Sep 30, 2013 | -5.65 Mn |
| Jun 30, 2013 | -3.94 Mn |
| Mar 31, 2013 | -939,000.00 |